NUCB2 and type 2 diabetes mellitus: However, lower nesfatin-1 levels in type 2 diabetes were evident in some subgroups, such as the homeostasis model assessment of insulin resistance (HOMA-IR) ratio (≥4), diagnosis criteria (ADA), and the blood sample source (serum).